 Connection
Andres Henao Martinez to Glucocorticoids
This is a "connection" page, showing publications Andres Henao Martinez has written about Glucocorticoids.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.273 |
|
|
|
-
Chastain DB, Thompson GR, Tuo Y, Henao-Martínez AF. Opportunistic fungal infection risk and mortality in non-HIV, non-transplant US adults receiving systemic glucocorticoids: An observational cohort study. Med Mycol. 2026 Feb 03; 64(2).
Score: 0.686
-
Chastain DB, Thompson GR, Henao-Martínez AF. Glucocorticoids, Concomitant Immunosuppression, and Pneumocystis jirovecii Pneumonia Prophylaxis Among US Adults. Clin Infect Dis. 2025 Dec 24; 81(5):1015-1018.
Score: 0.681
-
Chastain DB, Spradlin M, Ahmad H, Henao-Martínez AF. Unintended Consequences: Risk of Opportunistic Infections Associated With Long-term Glucocorticoid Therapies in Adults. Clin Infect Dis. 2024 04 10; 78(4):e37-e56.
Score: 0.605
-
Chastain DB, Spradlin M, Ahmad H, Henao-Martínez AF. Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults. Clin Infect Dis. 2024 04 10; 78(4):811-812.
Score: 0.151
-
Kim L, Ferraz C, Corbisiero MF, Gorvetzian S, Franco-Paredes C, Krsak M, Shapiro L, Thompson GR, Chastain DB, Tuells J, Henao-Martínez AF. Glucocorticoids as a risk factor for infection and adverse outcomes in non-HIV and non-transplant patients with cryptococcal meningitis. Mycoses. 2024 Mar; 67(3):e13709.
Score: 0.150
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|